Your browser doesn't support javascript.
loading
A Case of Hepatocellular Carcinoma with Pulmonary Metastasis Who Showed Complete Response by Cytotoxic Chemotherapy after Sorafenib Failure
Journal of Liver Cancer ; : 72-76, 2017.
Article in Korean | WPRIM | ID: wpr-156766
ABSTRACT
Hepatocellular carcinoma (HCC) is the 2nd most common cause of cancer related death in Korea and well-known malignancy with poor prognosis. Sorafenib is the first-line molecular targeted agent in patients with extra-hepatic spread of HCC. However, complete response is extremely rare in patients treated with sorafenib and the disease control rate is only 43%. We report a 53-year-old man with advanced HCC with pulmonary metastasis who showed complete response by cytotoxic chemotherapy with doxorubicin and cisplatin with relatively tolerable adverse effects after failure of treatment with sorafenib.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Prognosis / Doxorubicin / Cisplatin / Carcinoma, Hepatocellular / Drug Therapy / Korea / Neoplasm Metastasis Type of study: Prognostic study Limits: Humans Country/Region as subject: Asia Language: Korean Journal: Journal of Liver Cancer Year: 2017 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Prognosis / Doxorubicin / Cisplatin / Carcinoma, Hepatocellular / Drug Therapy / Korea / Neoplasm Metastasis Type of study: Prognostic study Limits: Humans Country/Region as subject: Asia Language: Korean Journal: Journal of Liver Cancer Year: 2017 Type: Article